ARX Sciences

ARX Sciences operates as a diversified supplier and contract manufacturer within the life sciences tools and diagnostic components sector. Founded in 2018 and headquartered in Buffalo, NY, the company has built a business model combining product distribution (antibodies, proteins, lab supplies) with higher-value contract development and manufacturing (CDMO) services for transport media and other IVD products. Its strategic focus on regulatory-compliant manufacturing and partnerships with global diagnostic companies positions it in the growing market for outsourced diagnostic production. The company appears to be revenue-generating, serving public health laboratories, veterinary markets, and commercial diagnostic partners.

cGMP/ISO 13485-compliant contract manufacturing platform for diagnostic components and reagents, with expertise in formulation of transport media and antibody validation.

ARX Sciences competes in two crowded fields: 1) the life science antibody/protein distribution market against giants like Thermo Fisher, Abcam, and Bio-Techne, and 2) the diagnostic CDMO space against large players (Catalent, Lonza) and many niche specialists. Its differentiation is its specific focus on IVD components, regulatory-ready facility, and flexibility in handling small-to-mid-size custom projects.